ArticleBioactive materials2026
An embolism-free nonfouling hydrogel coating with high toughness and lubricity for intravascular medical devices via chain-entanglement mediated topological gelation.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Recent Advances in Hydrogels as Therapeutic Tools for Spinal Cord Injury Regeneration.Tissue engineering and regenerative medicine · 2026Pooled it
- Chain entanglement-stabilized injectable zwitterionic hydrogel for vitreous replacement and retinal tamponade.National science review · 2026Article
- ZnO@TiOMaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogel coatings have become indispensable for advanced interventional devices owing to their exceptional lubricity, antithrombogenicity, and antibacterial performance. However, clinical adoption has been hindered by the risk of polymer embolism resulting from coating delamination in vascular systems. Herein, we report an embolism-free hydrogel coating strategy based on chain-entanglement-mediated topological gelation to address this limitation. Through an interface-regulated polymerization process, we fabricate a robust zwitterionic hydrogel coating stabilized by interfacial interlinking and enhanced polymer chain entanglement. This design delivers outstanding long-term antimicrobial and antithrombogenic properties and achieves high toughness, ultra-low friction, and wear resistance. Notably, the chain-entangled topological hydrogel exhibits a unique fail-safe mechanism: upon detachment, it undergoes spontaneous aqueous dissolution rather than forming hazardous debris. This approach can potentially reduce life-threatening complications in interventional therapies by eliminating the risk of polymer-induced embolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.